Patents by Inventor Siok Ping Yeo

Siok Ping Yeo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PD-L1 antibodies
    Patent number: 9789183
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: October 17, 2017
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo
  • Anti-PD-1 antibodies
    Patent number: 9771425
    Abstract: Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: September 26, 2017
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Jianrong Lionel Low, Hwee Ching Tan
  • Anti-CTLA-4 antibodies
    Patent number: 9758583
    Abstract: Anti-CTLA-4 antibodies are disclosed. Also disclosed are compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: September 12, 2017
    Assignee: Agency or Science, Technology and Research
    Inventors: Cheng-I Wang, Eve Ngoh, Siok Ping Yeo
  • ANTI-PD-1 ANTIBODIES
    Publication number: 20170240635
    Abstract: Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 24, 2017
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Jianrong Lionel Low, Hwee Ching Tan
  • Anti-TIM-3 Antibodies
    Publication number: 20170240633
    Abstract: Anti-TIM-3 antibodies are disclosed, as well as pharmaceutical compositions comprising such antibodies, and uses and methods using the same, such as in the treatment of cancer, infectious diseases, or T-cell dysfunctional disorders. Bispecific antibodies against TIM-3 and other targets are also disclosed, with preferred embodiment of a bispecific antibody against TIM-3 and CD3.
    Type: Application
    Filed: October 27, 2015
    Publication date: August 24, 2017
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Yun Pei Sharon Goh
  • ANTI-CTLA-4 ANTIBODIES
    Publication number: 20170226211
    Abstract: Anti-CTLA-4 antibodies are disclosed. Also disclosed are compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: April 13, 2017
    Publication date: August 10, 2017
    Inventors: Cheng-I Wang, Eve Ngoh, Siok Ping Yeo
  • IL2Rbeta/Common Gamma Chain Antibodies
    Publication number: 20160367664
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Application
    Filed: August 5, 2016
    Publication date: December 22, 2016
    Inventors: Cheng-I WANG, Peter BRAUER, Siok Ping YEO, Hwee Ching TAN, John Edward CONNOLLY
  • IL-1beta NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
    Publication number: 20150037248
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: February 13, 2013
    Publication date: February 5, 2015
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Mortellaro, Subhra Kumar, Florent Ginhoux, Pingyu Zhong